Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $435.79 million. The enterprise value is $279.68 million.
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TECX has 14.75 million shares outstanding. The number of shares has increased by 483.46% in one year.
| Current Share Class | 14.75M |
| Shares Outstanding | 14.75M |
| Shares Change (YoY) | +483.46% |
| Shares Change (QoQ) | +404.44% |
| Owned by Insiders (%) | 46.72% |
| Owned by Institutions (%) | 39.43% |
| Float | 3.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.90 |
| P/TBV Ratio | 2.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.39, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.39 |
| Quick Ratio | 9.19 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -448.72 |
Financial Efficiency
Return on equity (ROE) is -70.73% and return on invested capital (ROIC) is -41.99%.
| Return on Equity (ROE) | -70.73% |
| Return on Assets (ROA) | -36.18% |
| Return on Invested Capital (ROIC) | -41.99% |
| Return on Capital Employed (ROCE) | -35.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.22M |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +89.36% |
| 50-Day Moving Average | 42.33 |
| 200-Day Moving Average | 29.38 |
| Relative Strength Index (RSI) | 38.91 |
| Average Volume (20 Days) | 661,686 |
Short Selling Information
The latest short interest is 1.06 million, so 7.20% of the outstanding shares have been sold short.
| Short Interest | 1.06M |
| Short Previous Month | 661,086 |
| Short % of Shares Out | 7.20% |
| Short % of Float | 30.84% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.40M |
| Pretax Income | 30.68M |
| Net Income | -53.48M |
| EBITDA | -51.89M |
| EBIT | -53.40M |
| Earnings Per Share (EPS) | -$3.63 |
Full Income StatementBalance Sheet
The company has $159.10 million in cash and $2.98 million in debt, giving a net cash position of $156.11 million or $10.58 per share.
| Cash & Cash Equivalents | 159.10M |
| Total Debt | 2.98M |
| Net Cash | 156.11M |
| Net Cash Per Share | $10.58 |
| Equity (Book Value) | 150.36M |
| Book Value Per Share | 10.20 |
| Working Capital | 145.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$53.92 million and capital expenditures -$203,000, giving a free cash flow of -$54.12 million.
| Operating Cash Flow | -53.92M |
| Capital Expenditures | -203,000 |
| Free Cash Flow | -54.12M |
| FCF Per Share | -$3.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |